Duality Advisers’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Duality Advisers’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14,526	Closed	-$845K	–	748
2023 Q2	$845K	Buy	+14,526	New	+$916K	0.11%	315
2023 Q1	–	Sell	-38,995	Closed	-$2.48M	–	807
2022 Q4	$2.48M	Buy	38,995 +18,811	+93%	+$1.36M	0.28%	109
2022 Q3	$1.47M	Buy	+20,184	New	+$1.5M	0.16%	245

Other funds holding NARI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Duality Advisers's NARI Position: Q3 2023 in Review

Duality Advisers sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2023, closing a stake of 14,526 shares — an estimated $845K sold.

Duality Advisers first reported a position in NARI in Q3 2022 and held it in 3 quarters. The position peaked at $2.48M in Q4 2022. 250 funds tracked by Wall St. Rank hold NARI as of Q3 2023.

Duality Advisers reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Duality Advisers sold 14,526 Inari Medical, Inc. Common Stock shares in Q3 2023, an estimated $845K.
Duality Advisers first reported a position in Inari Medical, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
Duality Advisers's Inari Medical, Inc. Common Stock position peaked at $2.48M in Q4 2022.
250 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2023.

Based on Duality Advisers's 13F filing for Q3 2023, filed 2 Nov 2023.